Patent ID: 7759060
Filing Date: 2010-07-20
Classification: C12Q,G01N

Abstract:
1. A method for determining if prostate cells are cancerous, the method consisting of: a) obtaining said prostate cells; b) determining an expression of polynucleotides encoding Hepsin (transmembrane protease serine 1) genes in said prostate cells relative to normal prostate cells; c) determining an expression of polynucleotides encoding X-box binding protein 1 genes in said prostate cells relative to normal prostate cells; d) determining an expression of polynucleotides encoding Folate hydrolase (Prostate specific membrane antigen) 1 genes in said prostate cells relative to normal prostate cells; e) determining an expression of polynucleotides encoding Glutathione S-transferase M4 genes in said prostate cells relative to normal prostate cells; f) determining an expression of polynucleotides encoding Intersectin 1 (SH3 domain protein) genes in said prostate cells relative to normal prostate cells; g) determining an expression of polynucleotides encoding Nel-like 2 genes in said prostate cells relative to normal prostate cells; h) determining an expression of polynucleotides encoding D component of complement (adipsin) genes in said prostate cells relative to normal prostate cells; i) determining an expression of polynucleotides encoding Latent transforming growth factor beta binding protein 4 genes in said prostate cells relative to normal prostate cells; j) determining that said prostate cells are cancerous in the event that said polynucleotides encoding genes are overexpressed in said prostate cells relative to normal prostate cells and in the event that said polynucleotides encoding genes are underexpressed in said prostate cells relative to normal prostate cells.